HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uichi Nishiyama Selected Research

KRN383

12/2006Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Uichi Nishiyama Research Topics

Disease

1Carcinogenesis
03/2009
1Thrombocytopenia (Thrombopenia)
02/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2006
1Neoplasms (Cancer)
12/2006

Drug/Important Bio-Agent (IBA)

1Protein Tyrosine PhosphatasesIBA
03/2009
1Immunoglobulin G (IgG)IBA
02/2008
1AntibodiesIBA
02/2008
1Thrombopoietin (c-mpl Ligand)IBA
02/2008
1fms-Like Tyrosine Kinase 3IBA
12/2006
1KRN383IBA
12/2006

Therapy/Procedure

1Oral Administration
12/2006